Baculovirus Vaccine Candidate for Hand, Foot, and Mouth Disease
Author Information
Author(s): Meng Tao, Kolpe Annasaheb B., Kiener Tanja K., Chow Vincent T. K., Kwang Jimmy
Primary Institution: Temasek Life Sciences Laboratory, Republic of Singapore
Hypothesis
Can a baculovirus displaying the VP1 protein of Enterovirus 71 serve as an effective vaccine candidate?
Conclusion
The study found that the baculovirus displaying VP1 retained native epitopes and effectively induced an immune response against Enterovirus 71 in mice.
Supporting Evidence
- The baculovirus successfully displayed the VP1 protein on its surface.
- Immunization with the baculovirus induced high levels of neutralizing antibodies in mice.
- The vaccine candidate showed cross-neutralization against multiple EV71 subgenogroups.
Takeaway
Researchers created a new vaccine using a virus that helps make proteins, and it worked well in mice to protect against a common childhood illness.
Methodology
The study involved generating infectious EV71 viruses from synthetic cDNA and displaying the VP1 protein on baculovirus for immunization in mice.
Limitations
The study did not perform viral challenge experiments due to the lack of a suitable mouse model for human disease.
Participant Demographics
Female BALB/c mice, aged 4 weeks.
Statistical Information
P-Value
1:64
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website